Beurs gesloten -
Nasdaq
22:00:00 02-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
13,09
USD
|
-1,43%
|
|
-3,61%
|
-39,59%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
3.741
|
4.502
|
2.506
|
2.269
|
1.301
|
788,7
|
-
|
-
|
Bedrijfswaarde
1 |
2.732
|
2.841
|
763,7
|
996,6
|
547,7
|
285,5
|
458,5
|
315,4
|
K/w-verhouding
|
-5,4
x
|
7,57
x
|
-5,45
x
|
-4,25
x
|
-2,39
x
|
-2,01
x
|
-2,51
x
|
-4,49
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
545
x
|
4,04
x
|
397
x
|
295
x
|
15
x
|
18,4
x
|
5,98
x
|
2,6
x
|
Bedrijfswaarde/omzet
|
398
x
|
2,55
x
|
121
x
|
130
x
|
6,34
x
|
6,65
x
|
3,48
x
|
1,04
x
|
Bedrijfswaarde/EBITDA
|
-3,87
x
|
4,53
x
|
-1,67
x
|
-1,83
x
|
-0,95
x
|
-0,68
x
|
-1,34
x
|
-1,3
x
|
Bedrijfswaarde/FCF
|
-5,11
x
|
4,3
x
|
-2,02
x
|
-2,16
x
|
-1,01
x
|
-1,17
x
|
-2,34
x
|
-3,89
x
|
FCF Yield
|
-19,6%
|
23,3%
|
-49,6%
|
-46,3%
|
-98,8%
|
-85,5%
|
-42,8%
|
-25,7%
|
Price to Book
|
3,96
x
|
2,43
x
|
1,45
x
|
1,81
x
|
1,63
x
|
1,31
x
|
0,98
x
|
0,97
x
|
Aantal aandelen (in duizenden)
|
51.818
|
52.045
|
58.908
|
59.494
|
60.033
|
60.182
|
-
|
-
|
Referentieprijs
2 |
72,19
|
86,51
|
42,54
|
38,14
|
21,67
|
13,10
|
13,10
|
13,10
|
Datum van publicatie
|
27/02/20
|
24/02/21
|
24/02/22
|
16/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
6,868
|
1.114
|
6,308
|
7,686
|
86,46
|
42,96
|
131,9
|
303,3
|
EBITDA
1 |
-705,8
|
626,6
|
-456,7
|
-545,9
|
-578,5
|
-417
|
-342,5
|
-243,1
|
Bedrijfsresultaat (EBIT)
1 |
-708,1
|
624
|
-460,9
|
-547
|
-579,8
|
-425,5
|
-353
|
-213,3
|
Operationele Marge
|
-10.310,48%
|
56%
|
-7.306,74%
|
-7.116,69%
|
-670,69%
|
-990,44%
|
-267,56%
|
-70,35%
|
Resultaat voor belastingen (EBT)
1 |
-680,2
|
606,1
|
-457,9
|
-532,8
|
-541,5
|
-397,7
|
-330,1
|
-174,5
|
Nettowinst (verlies)
1 |
-680,2
|
606,1
|
-457,9
|
-532,8
|
-541,5
|
-396,6
|
-331,8
|
-200,9
|
Nettomarge
|
-9.904,46%
|
54,4%
|
-7.258,91%
|
-6.931,88%
|
-626,32%
|
-923,13%
|
-251,54%
|
-66,26%
|
WPA
2 |
-13,38
|
11,43
|
-7,800
|
-8,980
|
-9,050
|
-6,522
|
-5,221
|
-2,917
|
Free Cash Flow
1 |
-534,5
|
660,8
|
-378,6
|
-461
|
-541,1
|
-244,2
|
-196,3
|
-81,15
|
FCF-marge
|
-7.781,84%
|
59,31%
|
-6.001,17%
|
-5.997,57%
|
-625,92%
|
-568,51%
|
-148,8%
|
-26,76%
|
Kasstroomconversie (ebitda)
|
-
|
105,46%
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
109,03%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/02/20
|
24/02/21
|
24/02/22
|
16/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
1,642
|
1,582
|
1,501
|
1,739
|
2,865
|
3,294
|
2,474
|
2,716
|
77,97
|
7,902
|
9,184
|
11,54
|
14,3
|
24,42
|
34,21
|
EBITDA
1 |
-125,2
|
-119,4
|
-125,5
|
-140,1
|
-153,6
|
-158,3
|
-174,5
|
-182,9
|
-35,48
|
-118,9
|
-90,1
|
-78,7
|
-72,3
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-125,5
|
-123,2
|
-128,4
|
-141,5
|
-153,9
|
-155,5
|
-170,5
|
-178,2
|
-42,07
|
-117,7
|
-106,9
|
-102,2
|
-97,71
|
-93,25
|
-81,39
|
Operationele Marge
|
-7.642,33%
|
-7.787,55%
|
-8.554,76%
|
-8.135,71%
|
-5.371,8%
|
-4.719,79%
|
-6.889,94%
|
-6.562,96%
|
-53,96%
|
-1.489,18%
|
-1.164,21%
|
-885,93%
|
-683,54%
|
-381,93%
|
-237,92%
|
Resultaat voor belastingen (EBT)
1 |
-124,7
|
-122,1
|
-126,3
|
-137,3
|
-147,1
|
-146,8
|
-160,3
|
-201,6
|
-32,71
|
-108,5
|
-99,33
|
-95,17
|
-90,5
|
-80,59
|
-76,58
|
Nettowinst (verlies)
1 |
-124,7
|
-122,1
|
-126,3
|
-137,3
|
-147,1
|
-146,8
|
-160,3
|
-201,6
|
-32,71
|
-108,5
|
-99,7
|
-95,1
|
-90,53
|
-80,59
|
-76,58
|
Nettomarge
|
-7.595,13%
|
-7.715,23%
|
-8.411,73%
|
-7.896,66%
|
-5.135,99%
|
-4.457,44%
|
-6.480,4%
|
-7.423,78%
|
-41,95%
|
-1.372,85%
|
-1.085,63%
|
-824,35%
|
-633,28%
|
-330,06%
|
-223,87%
|
WPA
2 |
-2,120
|
-2,070
|
-2,130
|
-2,310
|
-2,470
|
-2,460
|
-2,680
|
-3,370
|
-0,5500
|
-1,800
|
-1,663
|
-1,588
|
-1,513
|
-1,573
|
-1,473
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
24/02/22
|
3/05/22
|
2/08/22
|
8/11/22
|
16/02/23
|
2/05/23
|
7/08/23
|
7/11/23
|
14/02/24
|
25/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.008
|
1.661
|
1.742
|
1.272
|
753
|
503
|
330
|
473
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-534
|
661
|
-379
|
-461
|
-541
|
-244
|
-196
|
-81,2
|
ROE (netto-inkomsten/eigen vermogen)
|
-75,3%
|
42%
|
-24,1%
|
-35,7%
|
-49,5%
|
-50,1%
|
-30,2%
|
-9,8%
|
ROA (netto-inkomsten/totale activa)
|
-66,8%
|
39,1%
|
-23%
|
-33,5%
|
-45,4%
|
-45,9%
|
-23,5%
|
-6%
|
Totale activa
1 |
1.018
|
1.551
|
1.992
|
1.591
|
1.193
|
863,8
|
1.410
|
3.351
|
Nettoactief per aandeel
2 |
18,20
|
35,50
|
29,30
|
21,00
|
13,30
|
10,00
|
13,40
|
13,50
|
Cashflow per aandeel
2 |
-10,40
|
12,50
|
-6,450
|
-7,760
|
-9,030
|
-4,930
|
-3,560
|
-0,6300
|
Capex
1 |
5,75
|
0,35
|
0,37
|
0,94
|
0,55
|
2,89
|
3,35
|
3,11
|
Capex/omzet
|
83,74%
|
0,03%
|
5,9%
|
12,19%
|
0,64%
|
6,74%
|
2,54%
|
1,03%
|
Datum van publicatie
|
27/02/20
|
24/02/21
|
24/02/22
|
16/02/23
|
14/02/24
|
-
|
-
|
-
|
Laatste slotkoers
13,1
USD Gemiddelde koersdoel
22,17
USD Spread / Gemiddelde doel +69,15% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -39,59% | 789 mln. | | -1,65% | 103 mld. | | +6,75% | 101 mld. | | +6,84% | 23,07 mld. | | -12,60% | 22,23 mld. | | -5,48% | 18,05 mld. | | -39,98% | 17,18 mld. | | -10,17% | 16,94 mld. | | +6,12% | 14,07 mld. | | +35,47% | 12,35 mld. |
Biotherapeutische geneesmiddelen
|